Skip to content

Paradoxical Excitement Response During Sedation Between Dexmedetomidine and Propofol in Hazardous Alcohol Drinker

Comparative Study on Development of Paradoxical Excitement Response During Sedation Using Dexmedetomidine or Propofol in Hazardous Alcohol Drinkers

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02197403
Acronym
DEX
Enrollment
110
Registered
2014-07-22
Start date
2013-12-31
Completion date
2019-05-31
Last updated
2019-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Drinking, Anesthesia, Epidural, Anesthesia, Spinal, Dexmedetomidine, Propofol, Sedation, Conscious

Keywords

Dexmedetomidine, Sedation, Paradoxical excitement response, Alcohol drinkers

Brief summary

1. Adequate sedation with classical sedative agents, propofol 2. Sedation with propofol may induce paradoxical excitement response in heavy alcohol drinkers 3. Dexmedetomidine, α2 receptor agonist, may provide adequate sedation in heavy alcohol drinkers

Detailed description

1. Adequate sedation during surgery provide anxiolysis and comfort to patient. Insufficient sedation can't provide comfort to patient during surgery, otherwise excessive sedation can cause variable complications like respiratory depression or delayed awakening. 2. Dexmedetomidine is a centrally acting α2 receptor agonist that is increasingly being used as a sedative for MAC and intensive care with mechanical ventilated patients because of its analgesic properties, cooperative sedation, and lack of respiratory depression. 3. Because of the different site of action between dexmedetomidine and propofol, we assumed that paradoxical excitement responses which appeared in heavy alcohol drinkers in midazolam or propofol-induced sedation might be less observed in dexmedetomidine-induced sedation.

Interventions

DRUGDexmedetomidine

200mcg in 50mL of normal saline 0.75mcg/Kg bolus injection in 10 minutes 0.1\ 1.0mcg/Kg infusion

DRUGPropofol

25\ 75mcg/kg/min continuous infusion

Sponsors

Chonnam National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 19\ 65 yr-old patients who is scheduled to undergo knee surgery with regional anesthesia

Exclusion criteria

* History of taking anxiolytics, hypnotics, antiepileptic drugs * Abnormal liver function test (eg: Liver cirrhosis, elevated liver enzymes) * History of allergic reaction with dexmedetomidine or propofol * Contraindication with regional anesthesia * American society of anesthesiologist Physical status III or IV

Design outcomes

Primary

MeasureTime frameDescription
Paradoxical excitement responseEvery 5 minutes up to 120minutes after drug infusionParadoxical excitement responses (verbal/movement) 0, none : no excitement response 1. mild : increased talkativeness, irrational talking / brief spontaneous movement with position remaining 2. moderate : restlessness, loss of cooperation, spontaneous movements requiring repositioning with no need of restraint 3. severe : agitation and spontaneous movements with a need to restrain the patient

Secondary

MeasureTime frameDescription
OAA/SEvery 5minutes up to 120minutes after drug infusionObserver''s Assessment of Alertness/Sedation Scale (OAA/S) 1. :Does not respond to mild prodding or shaking 2. :Responds only after mild prodding or shaking 3. :Responds only after name is spoken loudly and/or repeatedly 4. :Lethargic response to name spoken in normal tone 5. :Responds readily to name spoken in normal tone Goal to sedation : 3
Vital signsDuring operationCheck blood pressure, heart rate, oxygen saturation, bispectral index

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026